Delivery Order SPE2DB22D2006-SPE2DB26FV5YQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg under a firm fixed-price contract valued at $20,551.98. The award, made on September 24, 2025, represents a non-competitive delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $1,507.44 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Celecoxib 200 mg capsules in quantities of 500 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The award was issued from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,449.02 to AmerisourceBergen Drug Corp for 100 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) valued at $1,575.46. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Celebrex 200 mg capsules in unit dose packaging (100 count) with a contract value of $6,610.43. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,170.03 fixed-price contract is for the delivery of Celecoxib 200 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment facilities...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Celebrex 200 mg capsules in quantities of 100 units at a firm fixed price of $2,802.30. This contract represents a non-competitive delivery order without set-aside designation, with an ultimate completion date of August 14, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,408.14 firm fixed-price delivery order is for the supply of CELECOXIB 200 MG CAPSULE 500S, a medication used for various medical conditions. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,248.98, is for the delivery of 4,567,886,446 units of the drug Celecoxib 200 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,997.46 to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsules (100-count unit dose packaging) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5YQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication, valued at $1,031.41. The award, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, utilized firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as part of its ongoing federal medical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains and serves customers including the Defense Health Agency and the U.S. Coast Guard through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/31/25 |